We are monitoring the impact of COVID-19 on MEA Vaccine Adjuvant Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 628
Share on
Share on

Middle-East And Africa Vaccine Adjuvant Market Research Report – Segmented By Type, By Route Of Administration, By Mechanism Of Action And By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 628
Pages: 145

MEA Vaccine Adjuvant Market Size (2021 to 2026)

The size of the Vaccine Adjuvant Market in the Middle East & Africa is estimated to be worth USD 106 million by 2026 from USD 64.09 million in 2021, growing at a CAGR of 10.6% from 2021 to 2026.

The Adjuvants are immunological or pharmacological agents that support synergizing and leading the adaptive immune response to vaccine agents. The problem with unadulterated recombinant or engineered antigens used as a part of innovative vaccinations is that they are far less immunogenic than more experienced style lives or slaughtered complete living being antibodies. Therefore, it has made an essential requirement for improved and more powerful adjuvants for use in these immunizations.

The growth of this region owes to factors such as growing research and development expenditure and acquisitions that propel the market. However, lack of awareness, less prominence on research and development activities, and inadequate medical facilities are estimated to hamper the market growth in this region.

This research report on the MEA vaccine adjuvant market has been segmented and sub-segmented into the following categories:

By Type: 

  • Aluminum Salts
  • Tensoactive Adjuvants
  • Adjuvant Emulsions
  • Bacteria Derived Adjuvants
  • Liposome Adjuvants
  • Carbohydrate Adjuvants

By Route Of Administration: 

  • Oral
  • Intradermal
  • Subcutaneous
  • Intranasal
  • Intramuscular

By Mechanism Of Action: 

  • Immuno Stimulants
  • Carriers
  • Vehicle Adjuvants

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Regionally, Middle-East is estimated to dominate the region's vaccine adjuvant market in the forecast period. UAE Vaccine Adjuvant market leads the MEA market owing to the number of steps taken by the government towards the vaccination in children as there is an average increase of diseases and the growing number of awareness programs for promoting the treatments which drive the vaccine adjuvant market growth during the analysis period. However, the high cost of vaccine development is likely to hamper the market.

UAE follows Saudi Arabia, South Africa, and the Rest of MEA countries in having a high share of the market during the period. However, a lack of poor reimbursement policies from a few governments may restrict the adjuvant vaccine market.

KEY MARKET PLAYERS:

Companies playing an active role in the MEA vaccine adjuvant market profiled in this report are MPV Technologies, Avanti Polar Lipids, Novavax Inc. Brenntag Biosector, SEPPIC, Agenus, Inc., Invivogen, SPI Pharma, Inc., CSL Limited, and OZ Biosciences.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Aluminium Salts    

                                5.1.2 Tensoactive Adjuvants      

                                5.1.3 Adjuvant Emulsions            

                                5.1.4 Bacteria derived Adjuvants              

                                5.1.5 Liposome Adjuvants           

                                5.1.6 Carbohydrate Adjuvants   

                5.2 By Route of Administration                 

                                5.2.1 Oral            

                                5.2.2 Intradermal            

                                5.2.3 Subcutaneous       

                                5.2.4 Intranasal                

                                5.2.5 Intramuscular        

                5.3 By Mechanism of Action                       

                                5.3.1 Immuno Stimulants             

                                5.3.2 Carriers     

                                5.3.3 Vehicle Adjuvants

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 Middle-East                                

                6.3 Africa                            

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 MPV Technologies                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Avanti Polar Lipids                   

                8.3 Novavax Inc.                              

                8.4 Brenntag Biosector                 

                8.5 SEPPIC                          

                8.6 Agenus, Inc.                               

                8.7 Invivogen                    

                8.8 SPI Pharma Inc.                         

                8.9 CSL Limited                 

                8.10 OZ Biosciences                        

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Vaccine Adjuvant Market, By Region, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Vaccine Adjuvant Market, By Type, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Aluminium Salts Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Tensoactive Adjuvants Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Adjuvant Emulsions Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Bacteria derived Adjuvants Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Liposome Adjuvants Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Carbohydrate Adjuvants Market, By Region, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Vaccine Adjuvant Market, By Route of Administration, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Oral Market, By Region, From 2021 to 2026 (USD Million)
  11. Middle East & Africa Intradermal Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East & Africa Subcutaneous Market, By Region, From 2021 to 2026 (USD Million)
  13. Middle East & Africa Intranasal Market, By Region, From 2021 to 2026 (USD Million)
  14. Middle East & Africa Intramuscular Market, By Region, From 2021 to 2026 (USD Million)
  15. Middle East & Africa Vaccine Adjuvant Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  16. Middle East & Africa Immuno Stimulants Market, By Region, From 2021 to 2026 (USD Million)
  17. Middle East & Africa Carriers Market, By Region, From 2021 to 2026 (USD Million)
  18. Middle East & Africa Vehicle Adjuvants Market, By Region, From 2021 to 2026 (USD Million)
  19. Middle East Vaccine Adjuvant Market, By Type, From 2021 to 2026 (USD Million)
  20. Middle East Vaccine Adjuvant Market, By Route of Administration, From 2021 to 2026 (USD Million)
  21. Middle East Vaccine Adjuvant Market, By Mechanism of Action, From 2021 to 2026 (USD Million)
  22. Africa Vaccine Adjuvant Market, By Type, From 2021 to 2026 (USD Million)
  23. Africa Vaccine Adjuvant Market, By Route of Administration, From 2021 to 2026 (USD Million)
  24. Africa Vaccine Adjuvant Market, By Mechanism of Action, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample